Armada Acquisition Corp. I (AACI) 10-Q 14 Aug 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Jun. 30, 2023	Aug. 08, 2023
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Jun. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--09-30
Entity File Number	001-40742
Entity Registrant Name	Armada Acquisition Corp. I
Entity Central Index Key	0001844817
Entity Tax Identification Number	85-3810850
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	1760 Market Street
Entity Address, Address Line Two	Suite 602
Entity Address, City or Town	Philadelphia
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19103
City Area Code	215
Local Phone Number	543-6886
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		8,072,849
Common stock trades seperately		8,058,884
Units Each Consisting Of One Share Of Common Stock And Onehalf Of One Redeemable Warrant [Member]
Title of 12(b) Security	Units, each consisting of one share of Common Stock and one-half of one Redeemable Warrant
Trading Symbol	AACIU
Security Exchange Name	NASDAQ
Common Stock Par Value 0. 0001 Per Share [Member]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	AACI
Security Exchange Name	NASDAQ
Warrants Each Exercisable For One Share Of Common Stock For 11. 50 Per Share [Member]
Title of 12(b) Security	Warrants, each exercisable for one share of Common Stock for $11.50 per share
Trading Symbol	AACIW
Security Exchange Name	NASDAQ

CONDENSED BALANCE SHEETS

CONDENSED BALANCE SHEETS - USD ($)	Jun. 30, 2023	Sep. 30, 2022
Assets [Abstract]
Cash	$ 40,464	$ 177,578
Prepaid expenses	36,236	61,942
Total current assets	76,700	239,520
Investment held in Trust Account	37,158,121	150,844,925
Total Assets	37,234,821	151,084,445
Current liabilities:
Accounts payable	4,117,328	3,137,535
Franchise tax payable	122,000	150,000
Income tax payable	263,494	145,621
Excise tax payable	1,170,799	0
Total current liabilities	7,875,375	3,684,910
Commitments and Contingencies (Note 4)
Common stock subject to possible redemption, 3,508,852 and 15,000,000 shares at redemption value of $10.53 and $10.04 per share at June 30, 2023 and September 30, 2022, respectively	36,946,531	150,548,862
Stockholders' Deficit:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	0	0
Common stock, $0.0001 par value; 100,000,000 shares authorized, 5,709,500 shares issued and outstanding (excluding 3,508,852 and 15,000,000 shares subject to possible redemption) at June 30, 2023 and September 30, 2022, respectively	570	570
Additional paid-in capital	134,363	941,796
Accumulated deficit	(7,722,018)	(4,091,693)
Total Stockholders' Deficit	(7,587,085)	(3,149,327)
Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders' Deficit	37,234,821	151,084,445
Related Party [Member]
Current liabilities:
Promissory Notes-Related Party	$ 2,201,754	$ 251,754

CONDENSED BALANCE SHEETS (Paren

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2023	Sep. 30, 2022
Statement of Financial Position [Abstract]
Common stock subject to possible redemption, shares	3,508,852	15,000,000
Common stock subject to possible redemption, redemption value per share	$ 10.53	$ 10.04
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	1,000,000	1,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	5,709,500	5,709,500
Common Stock, Shares, Outstanding	5,709,500	5,709,500

CONDENSED STATEMENTS OF OPERATI

CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Formation and operating costs	$ 775,911	$ 1,522,131	$ 1,960,998	$ 3,889,792
Stock-based compensation	134,363	27,963	190,289	83,889
Loss from operations	(910,274)	(1,550,094)	(2,151,287)	(3,973,681)
Other income
Trust interest income	433,066	213,015	2,697,147	228,102
Total other income	433,066	213,015	2,697,147	228,102
(Loss) Income before provision for income taxes	(477,208)	(1,337,079)	545,860	(3,745,579)
Provision for income taxes	(82,376)	0	(525,560)	0
Net (loss) income	(559,584)	(1,337,079)	$ 20,300	$ (3,745,579)
Common Stock [Member]
Other income
Net (loss) income	$ 0	$ 0
Common Stock [Member] | Common stock subject to possible redemption [Member]
Other income
Basic weighted average shares outstanding	3,508,852	20,709,500	8,770,367	20,709,500
Diluted weighted average shares outstanding	3,508,852	20,709,500	8,770,367	20,709,500
Basic net income (loss) per share	$ (0.06)	$ (0.06)	$ 0	$ (0.18)
Diluted net income (loss) per share	$ (0.06)	$ (0.06)	$ 0	$ (0.18)
Common Stock [Member] | Non-redeemable common stock [Member]
Other income
Basic weighted average shares outstanding	5,709,500	20,709,500	5,709,500	20,709,500
Diluted weighted average shares outstanding	5,709,500	20,709,500	5,709,500	20,709,500
Basic net income (loss) per share	$ (0.06)	$ (0.06)	$ 0	$ (0.18)
Diluted net income (loss) per share	$ (0.06)	$ (0.06)	$ 0	$ (0.18)

CONDENSED STATEMENTS OF CHANGES

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]
Beginning balance, value at Sep. 30, 2021	$ 910,477	$ 683	$ 1,378,693	$ (468,899)
Beginning balance, shares at Sep. 30, 2021		6,834,500
Forfeiture of founder shares	0	$ (113)	113	0
Forfeiture of founder shares (in shares)		(1,125,000)
Stock-based compensation	27,963		27,963	0
Net (loss) income	(2,036,114)	$ 0	0	(2,036,114)
Ending balance, value at Dec. 31, 2021	(1,097,674)	$ 570	1,406,769	(2,505,013)
Ending balance, shares at Dec. 31, 2021		5,709,500
Beginning balance, value at Sep. 30, 2021	910,477	$ 683	1,378,693	(468,899)
Beginning balance, shares at Sep. 30, 2021		6,834,500
Excise tax payable on redemption	0
Net (loss) income	(3,745,579)
Ending balance, value at Jun. 30, 2022	(2,751,213)	$ 570	1,462,695	(4,214,478)
Ending balance, shares at Jun. 30, 2022		5,709,500
Beginning balance, value at Dec. 31, 2021	(1,097,674)	$ 570	1,406,769	(2,505,013)
Beginning balance, shares at Dec. 31, 2021		5,709,500
Stock-based compensation	27,963		27,963	0
Net (loss) income	(372,386)	$ 0	0	(372,386)
Ending balance, value at Mar. 31, 2022	(1,442,097)	$ 570	1,434,732	(2,877,399)
Ending balance, shares at Mar. 31, 2022		5,709,500
Stock-based compensation	27,963		27,963
Net (loss) income	(1,337,079)	$ 0		(1,337,079)
Ending balance, value at Jun. 30, 2022	(2,751,213)	$ 570	1,462,695	(4,214,478)
Ending balance, shares at Jun. 30, 2022		5,709,500
Beginning balance, value at Sep. 30, 2022	$ (3,149,327)	$ 570	941,796	(4,091,693)
Beginning balance, shares at Sep. 30, 2022	5,709,500	5,709,500
Stock-based compensation	$ 27,963		27,963	0
Remeasurement of common stock subject to possible redemption	(2,479,343)		0	(2,479,343)
Net (loss) income	607,027	$ 0	0	607,027
Ending balance, value at Dec. 31, 2022	(4,993,680)	$ 570	969,759	(5,964,009)
Ending balance, shares at Dec. 31, 2022		5,709,500
Beginning balance, value at Sep. 30, 2022	$ (3,149,327)	$ 570	941,796	(4,091,693)
Beginning balance, shares at Sep. 30, 2022	5,709,500	5,709,500
Excise tax payable on redemption	$ 1,170,799
Net (loss) income	20,300
Ending balance, value at Jun. 30, 2023	$ (7,587,085)	$ 570	134,363	(7,722,018)
Ending balance, shares at Jun. 30, 2023	5,709,500	5,709,500
Beginning balance, value at Dec. 31, 2022	$ (4,993,680)	$ 570	969,759	(5,964,009)
Beginning balance, shares at Dec. 31, 2022		5,709,500
Stock-based compensation	27,963		27,963	0
Cost of raising capital related to the stockholder non-redemption agreements			(1,102,909)
Capital contribution made by Sponsor related to the stockholder non-redemption agreements			1,102,909
Remeasurement of common stock subject to possible redemption	(669,074)		0	(669,074)
Excise tax payable on redemption	(1,170,799)		(997,722)	(173,077)
Net (loss) income	(27,143)	$ 0	0	(27,143)
Ending balance, value at Mar. 31, 2023	(6,832,733)	$ 570	0	(6,833,303)
Ending balance, shares at Mar. 31, 2023		5,709,500
Stock-based compensation	134,363		134,363
Remeasurement of common stock subject to possible redemption	(329,131)			(329,131)
Net (loss) income	(559,584)	$ 0		(559,584)
Ending balance, value at Jun. 30, 2023	$ (7,587,085)	$ 570	$ 134,363	$ (7,722,018)
Ending balance, shares at Jun. 30, 2023	5,709,500	5,709,500

UNAUDITED CONDENSED STATEMENTS

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 20,300	$ (3,745,579)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Interest earned on cash and marketable securities held in Trust Account	(2,697,147)	(228,102)
Stock-based compensation	190,289	83,889
Changes in current assets and liabilities:
Prepaid expenses	25,706	297,909
Accounts payable and accrued expenses	979,793	2,696,793
Income tax payable	117,873	0
Franchise tax payable	(28,000)	74,329
Net cash used in operating activities	(1,391,186)	(820,761)
Cash Flows from Investing Activities:
Withdrawals from trust for redemptions	117,079,879
Withdrawals from trust to pay for taxes	804,072	120,000
Principal deposited in Trust Account	(1,500,000)	0
Net cash provided by investing activities	116,383,951	120,000
Cash Flows from Financing Activities:
Proceeds from issuance of promissory note to related party	1,950,000	483,034
Redemptions of shares	(117,079,879)
Net cash provided by (used in) financing activities	(115,129,879)	483,034
Net change in cash	(137,114)	(217,727)
Cash, beginning of the period	177,578	657,590
Cash, end of the period	40,464	439,863
Supplemental disclosure of non-cash financing activities:
Remeasurement of common stock subject to possible redemption	3,477,548	0
Excise tax payable on redemption	$ 1,170,799	$ 0

Organization, Business Operatio

Organization, Business Operations and Going Concern	9 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Business Operations and Going Concern	Note 1 — Organization, Business Operations and Going Concern Armada Acquisition Corp. I (the “Company”) is a blank check company incorporated as a Delaware corporation on November 5, 2020. The Company was incorporated for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more businesses (the “Business Combination”). As more fully described in this Note 1, on December 17, 2021, the Company entered into a business combination agreement with a target business which was amended and restated on June 16, 2023. The Company concentrated its efforts in identifying businesses in the financial services industry with particular emphasis on businesses that are providing or changing technology for traditional financial services. As of June 30, 2023, the Company had not commenced any operations. All activity for the period from November 5, 2020 (inception) through June 30, 2023, relates to the Company’s formation and the initial public offering (the “IPO”) described below, and since the closing of the IPO, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating The Company’s sponsor is Armada Sponsor LLC (the “Sponsor”). The registration statement for the Company’s IPO was declared effective on August 12, 2021 (the “Effective Date”). On August 17, 2021, the Company commenced the IPO of 15,000,000 units at $10.00 per unit (the “Units”). Simultaneously with the consummation of the IPO, the Company consummated the private placement of 459,500 shares of common stock (“Private Shares”), at a price of $10.00 per share for an aggregate purchase price of $4,595,000. Transaction costs amounted to $3,537,515 consisting of $1,500,000 of underwriting commissions, and $2,037,515 of other offering costs. Following the closing of the IPO on August 17, 2021, after releasing funds to the Company to be held outside of the Trust, $150,000,000 ($10.00 per Unit) from the net proceeds of the sale of the Units in the IPO was held in a Trust Account (“Trust Account”) and has been invested only in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule2a-7 The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of Private Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the value of the assets held in the trust account (as defined below) (excluding deferred underwriting commissions and taxes payable) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to complete a Business Combination successfully. In connection with any proposed Business Combination, the Company will either (1) seek stockholders approval of the initial Business Combination at a meeting called for such purpose at which stockholders may seek to redeem their shares, regardless of whether they vote for or against the proposed Business Combination or do not vote at all, into their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable), or (2) provide its stockholders with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount equal to their pro rata share of the aggregate amount then on deposit in the Trust Account (net of taxes payable and less up to $100,000 of interest to pay dissolution expenses), in each case subject to the limitations described herein. The decision as to whether the Company will seek stockholders approval of a proposed Business Combination or will allow stockholders to sell their shares to the Company in a tender offer will be made by the Company, solely in its discretion. The shares of common stock subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480,“Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. Following the exercise of the automatic extension of the deadline for the Company to complete an initial business combination under our second amended and restated certificate of incorporation, the Company had until February 17, 2023 (or 18 months following our initial public offering) to consummate a business combination (unless we further extend the period of time to consummate a business combination) (the “Combination Period”). As further described in Note 1, on February 2, 2023, the stockholders approved an amendment to our certificate of incorporation to extend the date by which we must ”) until August 17, 2023, and on August 2, 2023, the stockholders approved a further amendment to our certificate of incorporation to extend the Combination Period until no later than February 17, 2024. On August 8, 2023, the Company borrowed $70,900 under the Extension Note (as defined below) and deposited the funds into the Trust Account thereby extending the Combination Period until September 17, 2023. The Sponsor, officers and directors have agreed (i) to vote any shares owned by them in favor of any proposed Business Combination, (ii) not to redeem any shares in connection with a stockholder vote to approve a proposed initial Business Combination or sell any shares to the Company in a tender offer in connection with a proposed initial Business Combination, (iii) that the founders’ shares will not participate in any liquidating distributions from the Company’s Trust Account upon winding up if a Business Combination is not consummated. The Sponsor has agreed that it will be liable to ensure that the proceeds in the Trust Account are not reduced below $10.00 per share by the claims of target businesses or claims of vendors or other entities that are owed money by the Company for services rendered or contracted for or products sold to the Company. The agreement to be entered into by the Sponsor will specifically provide for two exceptions to the indemnity it has given: it will have no liability (1) as to any claimed amounts owed to a target business or vendor or other entity who has executed an agreement with the Company waiving any right, title, interest or claim of any kind they may have in or to any monies held in the Trust Account, or (2) as to any claims for indemnification by the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has it independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company believes it is unlikely that the Sponsor will be able to satisfy its indemnification obligations if it is required to do so. On December 17, 2021, the Company entered into a business combination agreement with Rezolve Limited, a private limited company incorporated under the laws of England and Wales (“ Rezolve Cayman NewCo Rezolve Merger Sub Business Combination Agreement Business Combination On November 10, 2022, the Company and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement” and the business combination contemplated thereby, the “Business Combination”), to among other things, extend the date on which either party to the Business Combination Agreement had the right to terminate the Business Combination Agreement if the Business Combination had not been completed by such date to the later of (i) January 31, 2023 or (ii) fifteen days prior to the last date on which the Company may consummate a Business Combination, and change the structure of the Business Combination such that Cayman NewCo is no longer a party to the Business Combination Agreement or the Business Combination. On February 2, 2023, the Company held an annual meeting of its stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Second Amended and Restated Certificate of Incorporation (“Charter”) to extend the date by which the Company must consummate a business combination or, if it fails to do so, cease its operations and redeem or repurchase 100% of the shares of the Company’s Common Stock issued in the Company’s initial public offering, from February 17, 2023 for up to six additional months at the election of the Company, ultimately until as late as August 17, 2023 (the “Extension”). The Company filed an amendment to the Company’s Charter with the Secretary of State of the State of Delaware reflecting the Extension. In connection with the Extension, the holders of 11,491,148 shares of Common Stock elected to redeem their shares at a per share redemption price of approximately $10.19. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders. On February 23, 2023, Armada, Rezolve and YA II PN, Ltd., a Cayman Islands exempted limited partnership (“YA”) entered into Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to $250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement. On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $ 1.60 pre-Closing “Pre-Closing Pre-Closing Pre-Closing Concurrently with the execution and delivery of the Amended and Restated Business Combination Agreement, Armada and the Key Company Shareholders (as defined in the Amended and Restated Business Combination Agreement) have entered into the Transaction Support Agreement, pursuant to which, among other things, the Key Company Shareholders have agreed to (a) vote in favor of the Company Reorganization (b) vote in favor of the Amended and Restated Business Combination Agreement and the agreements contemplated thereby and the transactions contemplated thereby, (c) enter into the Investor Rights Agreement (as defined in the Amended and Restated Business Combination Agreement) at Closing and (d) the termination of certain agreements effective as of Closing. On August 2, 2023, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which Armada has to consummate a Business Combination from August 17, 2023 (the “Original Termination Date”) to September 17, 2023 (the “Charter Extension Date”) and to allow Armada, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of Armada’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Second Extension Amendment Proposal”). The stockholders of Armada approved the Second Extension Amendment Proposal at the special meeting and on August 3, 2023, Armada filed the Charter Amendment with the Delaware Secretary of State. In connection with the vote to approve the Charter Amendment, the holders of 1,145,503 public shares of Common Stock of Armada exercised their right to redeem their shares for cash at a redemption price of approximately $10.56 per share, for an aggregate redemption amount of approximately $12,095,215. In connection with the approval of the Second Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $425,402 (the “Extension Note”) to the Sponsor. The Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that Armada does not consummate a Business Combination, the Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $70,900 to be deposited into the Trust Account within five business days following approval of the Charter Amendment by the Company’s stockholders, and up to $354,502 in five equal installments to be deposited into the Trust Account for each of the five one-month extensions. On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023. Liquidity and Going Concern The accompanying financial statements have been prepared assuming the Company will continue as a going concern, which contemplates, among other things, the realization of assets and satisfaction of liabilities in the normal course of business. As of June 30, 2023, the Company had approximately $40,000 in its operating account and working capital deficiency of approximately $7.6 million (excluding income tax payable and franchise tax payable). Prior to the completion of the IPO, the Company’s liquidity needs have been satisfied through the $36,045 proceeds received from the sale of its Founder Shares to the Sponsor, the advances of $230,352 from the Sponsor to cover the Company’s offering costs in connection with the IPO, and the net proceeds from the consummation of the Private Placement not held in the Trust Account. The balance of the advances from Sponsor was fully repaid on August 17, 2021. On May 9, 2022, the Sponsor loaned the Company the aggregate amount of $483,034 in order to assist the Company to fund its working capital needs. On November 10, 2022 the Sponsor loaned the Company $1,500,000 in order to cover the additional contribution to the trust account in connection with the automatic extension and $450,000 to fund its working capital needs (see Note 3). These loans are evidenced by four promissory notes in the aggregate principal amount of $2,433,034 from the Company, as maker, to the Sponsor, as payee. The promissory notes are non-interest In order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company with Working Capital Loans, as defined below (see Note 3). As of June 30, 2023, there were no amounts outstanding under any Working Capital Loans. The Company has incurred and expects to continue to incur significant costs in pursuit of its acquisition plans. In connection with the Company’s assessment of going concern considerations in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Update(“ASU”) 2014-15,“Disclosures Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1% excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations occurring on or after January 1, 2023. The excise tax is imposed on the repurchasing corporation itself, not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. Any redemption or other repurchase that occurs on or after January 1, 2023, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection with the Business Combination, extension or otherwise, (ii) the structure of the Business Combination, (iii) the nature and amount of any “PIPE” or other equity issuances in connection with the Business Combination (or otherwise issued not in connection with the Business Combination but issued within the same taxable year of the Business Combination) and (iv) the content of regulations and other guidance from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand to complete a Business Combination and in the Company’s ability to complete a Business Combination. The Company has agreed that any such excise taxes shall not be paid from the interest earned on the funds held in the Trust Account. As discussed above, during February 2023, holders of 11,491,148 shares of Common Stock elected to redeem their shares in connection with the Extension. As a result, $117,079,879 was removed from the Company’s Trust Account to pay such holders. Management has evaluated the requirements of the IR Act and the Company’s operations, and has determined that a liability of $1,170,799 is required to be recorded as of June 30, 2023. This liability will be reevaluated and remeasured at the end of such subsequent period until it is settled.

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Significant Accounting Policies	Note 2 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three and nine months ended June 30, 2023, are not necessarily indicative of the results that may be expected through September 30, 2023. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form10-K, Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $40,464 and $177,578 in cash as of June 30, 2023 and September 30, 2022, respectively. Investment Held in Trust Account As of June 30, 2023 the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in trust interest income on Investments Held in Trust Account in the accompanying condensed statement of operations. As September 30, 2022, the assets held in the Trust Account were held in U.S. Treasury Bills with a maturity of 185 days or less and in money market funds which invest in U.S. Treasury securities. The Company classifies its U.S. Treasury bills as held-to-maturity Held-to-maturity Held-to-maturity A decline in the market value of held-to-maturity year-end, Premiums and discounts are amortized or accreted over the life of the related held-to-maturity There were no held to maturity securities on June 30, 2023. The carrying value, excluding gross unrealized holding loss, and fair value of held to maturity securities on September 30, 2022 is as follows: Carrying Value as of September 30, 2022 Gross Unrealized Gains Gross Unrealized Losses Fair Value as of September 30, 2022 Cash $ 320 $ — $ — $ 320 U.S. Treasury Bills 150,844,605 19,242 — 150,863,847 $ 150,844,925 $ 19,242 $ — $ 150,864,167 Held to maturity investments (U.S. Treasury Bills) recorded as of September 30, 2022 matured on October 22, 2022 and the total amount of $151,046,320, including amortized interest, was reinvested in money market funds. The estimated fair values of investments held in the Trust Account are determined using available market information and are characterized as Level 1 investments within the fair value hierarchy under ASC 820 (as described below). Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement” approximates the carrying amounts represented in the condensed balance sheets. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At June 30, 2023 and September 30, 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. Offering Costs Associated with IPO The Company complies with the requirements ofASC340-10-S99-1and Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480,“Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 15,000,000 shares of common stock as of September 30, 2022, and 3,508,852 shares of common stock as of June 30, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in At June 30, 2023 and September 30, 2022, the common stock reflected in the balance sheets are reconciled in the following table: Gross Proceeds $ 150,000,000 Proceeds allocated to Public Warrants (11,700,000 ) Issuance costs related to common stock (3,261,589 ) Remeasurement of carrying value to redemption value 14,961,589 Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes) 548,862 Common stock subject to possible redemption – September 30, 2022 150,548,862 Redemptions (117,079,879 ) Remeasurement of carrying value to redemption value 3,477,548 Common stock subject to possible redemption – June 30, 2023 $ 36,946,531 Net Income (Loss) Per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of June 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. Accretion of the carrying value of common stock subject to redemption value is excluded from net income (loss) per common stock because the redemption value approximates fair value. For the Three Months Ended June 30, 2023 2022 Common stock subject to redemption Common stock Common stock subject to redemption Common stock Basic and diluted net loss per share Numerator: Allocation of net loss $ (212,999 ) $ (346,585 ) $ (968,453 ) $ (368,626 ) Denominator Weighted-average shares outstanding 3,508,852 5,709,500 15,000,000 5,709,500 Basic and diluted net loss per share $ (0.06 ) $ (0.06 ) $ (0.06 ) $ (0.06 ) For the Nine Months Ended June 30, 2023 2022 Common stock subject to redemption Common stock Common stock subject to redemption Common stock Basic and diluted net income (loss) per share Numerator: Allocation of net income (loss) $ 12,296 $ 8,004 $ (2,712,943 ) $ (1,032,636 ) Denominator Weighted-average shares outstanding 8,770,367 5,709,500 15,000,000 5,709,500 Basic and diluted net income (loss) per share $ 0.00 $ 0.00 $ (0.18 ) $ (0.18 ) Stock-Based Compensation The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”) which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the condensed statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional paid-in On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three 27,963 and $ compensation for the three and nine months ended June 30, 2023, and 2022, respectively. At June 30, 2023, there are 11,250 shares that remain unvested. Total unrecognized compensation expense related to the unvested shares at June 30, 2023 amounted to $27,965 and is expected to be recognized through August 17, 2023 On June 26, 2023, the Sponsor allocated 270,000 90,000 100,000 207,200 190,000 180,000 90,000 90,000 Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and September 30, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As of June 30, 2023, and September 30, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was 96.28 0.00 Our effective tax rate was 17.26% and 0.00% for the three months ended June 30, 2023 and 2022. 21 n and stock-based compensation expenses. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Jun. 30, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 3 — Related Party Transactions Promissory Notes-Related Party On May 9, 2022, the Sponsor loaned the Company the aggregate amount of $483,034 in order to assist the Company to fund its working capital needs. The loan is evidenced by two promissory notes in the aggregate principal amount of $483,034 from the Company, as maker, to the Sponsor, as payee. On November 10, 2022 the Sponsor loaned the Company $1,500,000 in order to cover the additional contribution to the trust account in connection with the automatic extension and $450,000 to fund its working capital needs. The promissory notes are non-interest During July 2022, the Company fully repaid one of the promissory notes in the amount of $187,034 which represented monies loaned to the Company for the payment of Delaware franchise taxes. The Company utilized the interest earned on the Trust Account to repay the promissory note. The Company also paid $44,246 on behalf of the Sponsor for tax services in August and September 2022. The aggregate balance outstanding under all promissory notes was $2,201,754 and $251,754 as of June 30, 2023 and September 30, 2022, respectively. Working Capital Loans In order to meet the Company’s working capital needs following the consummation of the IPO, the Sponsor, officers, directors or their affiliates may, but are not obligated to, loan the Company funds (“Working Capital Loans”), from time to time or at any time, in whatever amount they deem reasonable in their sole discretion. Each loan would be non-interest Administrative Service Fee Commencing on the date of the IPO, the Company will pay the Sponsor $10,000 per month for office space, utilities and secretarial support. Upon completion of the initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees. For each of the three and nine months ended June 30, 2023 and 2022, the Company incurred and paid $30,000 and $90,000, respectively, in administrative service fees.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 4 — Commitments and Contingencies Registration Rights The holders of the Founder Shares issued and outstanding on the date of the IPO, as well as the holders of the representative shares, Private Shares and any shares the Company’s Sponsor, officers, directors or their affiliates may issue in payment of Working Capital Loans made to the Company, will be entitled to registration rights pursuant to an agreement signed on the effective date of the IPO. The holders of a majority of these securities (other than the holders of the representative shares) are entitled to make up to two demands that the Company registers such securities. The holders of the majority of the Founder Shares can elect to exercise these registration rights at any time commencing three months prior to the date on which these shares of common stock are to be released from escrow. The holders of a majority of the Private Shares and shares issued to the Company’s Sponsor, officers, directors or their affiliates in payment of Working Capital Loans made to the Company can elect to exercise these registration rights at any time after the Company consummates a Business Combination. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s consummation of a Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The underwriters were paid a cash underwriting discount of 1.0% of the gross proceeds of the IPO, or $1,500,000 (and are entitled to an additional $225,000 of deferred underwriting commission payable at the time of an initial Business Combination if the underwriters’ over-allotment is exercised in full). On October 1, 2021 the underwriters’ over-allotment option expired unused resulting in the $225,000 deferred underwriting commission to be not payable to the underwriter. Financial Advisory Fee The Company engaged Cohen & Company Capital Markets, a division of J.V.B. Financial Group, LLC (“CCM”), an affiliate of a member of the Sponsor, to provide consulting and advisory services in connection with the IPO, for which it received an advisory fee equal to one (1.0) percent of the aggregate proceeds of the IPO, or $1,500,000, upon closing of the IPO. Affiliates of CCM have and manage investment vehicles with a passive investment in the Sponsor. On August 18, 2021, the Company paid to CCM in aggregate of $1,500,000. CCM is engaged to represent the Company’s interests only. The Company engaged CCM as a capital markets advisor in connection with the initial Business Combination for which it will earn an advisory fee of payable at closing of the Business Combination. The Company also engaged CCM as a financial advisor in connection with the initial Business Combination for which it will earn an advisory fee of at closing of the Business Combination. Business Combination Marketing Agreement The Company engaged Northland Securities, Inc., the representative of the underwriters, as an advisor in connection with Business Combination to assist in holding meetings with the Company’s stockholders to discuss the potential Business Combination and the target business’ attributes, introduce the Company to potential investors that are interested in purchasing the Company’s securities in connection with the initial Business Combination and assist the Company with press releases and public filings in connection with the Business Combination. The Company will pay the representative a cash fee for such services upon the consummation of the initial Business Combination in an amount equal to 2.25% of the gross proceeds of the IPO, or $3,375,000. The Company will also pay the representative a separate capital market advisory fee of $2,500,000 upon completion of the initial Business Combination. Additionally, the Company will pay the representative a cash fee equal to 1.0% of the total consideration payable in the proposed Business Combination if the representative introduces the Company to the target business with which the Company completes a Business Combination. On February 8, 2021, Northland purchased 87,500 shares of common stock at an average purchase price of approximately $0.0001 per share. On May 29, 2021, Northland returned these 87,500 shares of common stock to the Company, for no consideration, which were subsequently cancelled. We also will pay to the representative at the time of the closing of the initial Business Combination, $1,030,000 due under two separate engagement letters in connection with fairness opinions delivered to our Board of Directors. An aggregate of $120,000 has already been paid under these engagement letters and expensed in the Company’s statement of operations . On November 10, 2022, the Company and Rezolve entered into a First Amendment to the Business Combination Agreement (the “Amendment,” and together with the Original Business Combination Agreement, the “Business Combination Agreement” and the business combination contemplated thereby, the “Business Combination”), to among other things, extend the date on which either party to the Business Combination Agreement had the right to terminate the Business Combination Agreement if the Business Combination had not been completed by such date to the later of (i) January 31, 2023 or (ii) fifteen days prior to the last date on which the Company may consummate a Business Combination, and change the structure of the Business Combination such that Cayman NewCo is no longer a party to the Business Combination Agreement or the Business Combination. On June 16, 2023, the Company, Rezolve, Rezolve AI Limited, a private limited liability company incorporated under the laws of England and Wales (“Rezolve AI”) and Rezolve Merger Sub amended and restated the Business Combination Agreement (the “Amended and Restated Business Combination Agreement”) by way of a Deed of Release, Amendment and Restatement to, among other things, amend (a) the enterprise value of Rezolve by which the aggregate stock consideration is calculated to $1.60 billion, and (b) provide for (i) a pre-Closing “Pre-Closing Pre-Closing Pre-Closing Non-Redemption On January 20, 2023, the Company and its Sponsor, entered into one or more agreements (the “Non-Redemption Non-Redemption Non-Redemption Non-Redeeming paid-in Non-Redemption Right of First Refusal If the Company determines to pursue any equity, equity-linked, debt or mezzanine financing relating to or in connection with an initial Business Combination, then Northland Securities, Inc. shall have the right, but not the obligation, to act as book running manager, placement agent and/or arranger, as the case may be, in any and all such financing or financings. This right of first refusal extends from the date of the IPO until the earlier of the consummation of an initial Business Combination or the liquidation of the Trust Account if the Company fails to consummate a Business Combination during the required time period. Purchasing Agreement On February 23, 2023, Armada, Rezolve and YA II PN, Ltd., a Cayman Islands exempted limited partnership (“YA”) entered into Standby Equity Purchase Agreement (the “Purchase Agreement”), pursuant to which, among other things, upon the closing of the Business Combination, Rezolve shall have the right to issue and sell to YA up to $250 million of the ordinary shares of Rezolve during the 36 month period following the closing of the Business Combination. Rezolve will not be obligated to draw any amount under the Agreement, will control both the timing and amount of all drawdowns, and will issue stock to YA on each drawn down from the facility. Subject to closing of the Business Combination, Rezolve must file and maintain a registration statement, or multiple registration statements, for resale by YA of the shares. If the Business Combination Agreement is terminated, other than in connection with the consummation of the Business Combination, then the Purchase Agreement shall be terminated and of no further effect, without any liability of any party thereunder. Other than making appropriate disclosure of the Purchase Agreement under the Federal securities laws, the Company has no obligations under the Purchase Agreement.

Recurring Fair Value Measuremen

Recurring Fair Value Measurements	9 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Recurring Fair Value Measurements	Note 5 — Recurring Fair Value Measurements As of June 30, 2023, the assets held in the Trust Account were held in money market funds which invest in U.S. Treasury securities. As of September 30, 2022, the assets held in the Trust Account were held in U.S. Treasury Bills with a maturity of 185 days or less. There were no transfers between Levels 1, 2 or 3 during the nine months ended June 30, 2023 and 2022.

Subsequent Events

Subsequent Events	9 Months Ended
	Jun. 30, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 6 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, other than as disclosed below, the Company did not identify any subsequent events that would have required adjustment or disclosure in these unaudited condensed financial statements. On July 28, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $125,245. The promissory note is non-interest report. On August 2, 2023, the Company held a special meeting of its stockholders to approve an amendment to its Charter (the “Charter Amendment”) to extend the date (the “Termination Date”) by which Armada has to consummate a Business Combination from August 17, 2023 (the “Original Termination Date”) to September 17, 2023 (the “Charter Extension Date”) and to allow Armada, without another stockholder vote, to elect to extend the Termination Date to consummate a Business Combination on a monthly basis up to five times by an additional one month each time after the Charter Extension Date, by resolution of Armada’s board of directors, if requested by the Sponsor, and upon five days’ advance notice prior to the applicable Termination Date, until February 17, 2024, or a total of up to six months after the Original Termination Date, unless the closing of a Business Combination shall have occurred prior thereto (the “Second Extension Amendment Proposal”). The stockholders of Armada approved the Second Extension Amendment Proposal at the special meeting and on August 3, 2023, Armada filed the Charter Amendment with the Delaware Secretary of State. In connection with the vote to approve the Charter Amendment, the holders of 1,145,503 public shares of Common Stock of Armada exercised their right to redeem their shares for cash at a redemption price of approximately $10.56 per share, for an aggregate redemption amount of approximately $12,095,215. In connection with the approval of the Second Extension Amendment Proposal, the Company issued an unsecured promissory note in the principal amount of up to $425,402 (the “Extension Note”) to the Sponsor. The Extension Note does not bear interest and matures upon closing of the Business Combination. In the event that Armada does not consummate a Business Combination, the Note will be repaid only from funds held outside of the Trust Account or will be forfeited, eliminated or otherwise forgiven. The proceeds of the Note will be deposited in the Trust Account in connection with the Charter Amendment as follows: $70,900 to be deposited into the Trust Account within five business days following approval of the Charter Amendment by the Company’s stockholders, and up to $354,502 in five equal installments to be deposited into the Trust Account for each of the five one-month extensions. On August 4, 2023, Armada, Rezolve, Rezolve AI, and Rezolve Merger Sub amended the Business Combination Agreement to remove the requirement that after giving effect to the transactions contemplated by the Business Combination Agreement, Rezolve shall have at least $5,000,001 of net tangible assets (as determined in accordance with Rule 3a51-1(g)(1) On August 8, 2023, the Company borrowed $70,900 under the Extension Note and deposited the funds into the Trust Account thereby extending the Termination Date to September 17, 2023. On August 9, 2023, the Company issued a promissory note to the Sponsor for the aggregate amount of $91,740.50 to be used for working capital

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (“SEC”). Accordingly, they do not include all of the information and footnotes required by US GAAP. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made that are necessary to present fairly the financial position, and the results of its operations and its cash flows for the period presented in the unaudited condensed financial statements. Operating results for the three and nine months ended June 30, 2023, are not necessarily indicative of the results that may be expected through September 30, 2023. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form10-K,
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $40,464 and $177,578 in cash as of June 30, 2023 and September 30, 2022, respectively.
Investment Held in Trust Account	Investment Held in Trust Account As of June 30, 2023 the assets held in the Trust Account were held in a money market fund. The Company’s portfolio of investments held in the Trust Account is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, investments in money market funds that invest in U.S. government securities, cash, or a combination thereof. The Company’s investments held in the Trust Account are classified as trading securities. Trading securities are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities is included in trust interest income on Investments Held in Trust Account in the accompanying condensed statement of operations. As September 30, 2022, the assets held in the Trust Account were held in U.S. Treasury Bills with a maturity of 185 days or less and in money market funds which invest in U.S. Treasury securities. The Company classifies its U.S. Treasury bills as held-to-maturity Held-to-maturity Held-to-maturity A decline in the market value of held-to-maturity year-end, Premiums and discounts are amortized or accreted over the life of the related held-to-maturity There were no held to maturity securities on June 30, 2023. The carrying value, excluding gross unrealized holding loss, and fair value of held to maturity securities on September 30, 2022 is as follows: Carrying Value as of September 30, 2022 Gross Unrealized Gains Gross Unrealized Losses Fair Value as of September 30, 2022 Cash $ 320 $ — $ — $ 320 U.S. Treasury Bills 150,844,605 19,242 — 150,863,847 $ 150,844,925 $ 19,242 $ — $ 150,864,167 Held to maturity investments (U.S. Treasury Bills) recorded as of September 30, 2022 matured on October 22, 2022 and the total amount of $151,046,320, including amortized interest, was reinvested in money market funds. The estimated fair values of investments held in the Trust Account are determined using available market information and are characterized as Level 1 investments within the fair value hierarchy under ASC 820 (as described below).
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. The fair value of certain of the Company’s assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurement” approximates the carrying amounts represented in the condensed balance sheets.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Corporation limit of $250,000. At June 30, 2023 and September 30, 2022, the Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.
Offering Costs Associated with IPO	Offering Costs Associated with IPO The Company complies with the requirements ofASC340-10-S99-1and
Common Stock Subject to Possible Redemption	Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in ASC Topic 480,“Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption (if any) are classified as a liability instrument and measured at fair value. Conditionally redeemable common stock (including common stock that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, common stock are classified as stockholders’ equity. The Company’s shares of common stock feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, 15,000,000 shares of common stock as of September 30, 2022, and 3,508,852 shares of common stock as of June 30, 2023 subject to possible redemption are presented at redemption value as temporary equity, outside of the stockholders’ deficit section of the Company’s condensed balance sheets. The Company recognizes changes in redemption value immediately as they occur. Immediately upon the closing of the IPO, the Company recognized the remeasurement adjustment from initial carrying amount to redemption book value. The change in the carrying value of redeemable common stock resulted in charges against additional paid-in At June 30, 2023 and September 30, 2022, the common stock reflected in the balance sheets are reconciled in the following table: Gross Proceeds $ 150,000,000 Proceeds allocated to Public Warrants (11,700,000 ) Issuance costs related to common stock (3,261,589 ) Remeasurement of carrying value to redemption value 14,961,589 Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes) 548,862 Common stock subject to possible redemption – September 30, 2022 150,548,862 Redemptions (117,079,879 ) Remeasurement of carrying value to redemption value 3,477,548 Common stock subject to possible redemption – June 30, 2023 $ 36,946,531
Net Income (Loss) Per Common Stock	Net Income (Loss) Per Common Stock The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share”. Net income (loss) per common stock is computed by dividing net income (loss) by the weighted average number of common stock outstanding for the period. Remeasurement adjustments associated with the redeemable shares of common stock is excluded from earnings per share as the redemption value approximates fair value. The calculation of diluted income (loss) per share does not consider the effect of the warrants issued in connection with the IPO because the warrants are contingently exercisable, and the contingencies have not yet been met. The warrants are exercisable to purchase 7,500,000 shares of common stock in the aggregate. As of June 30, 2023 and 2022, the Company did not have any dilutive securities or other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted net income (loss) per common stock is the same as basic net income (loss) per common stock for the periods presented. Accretion of the carrying value of common stock subject to redemption value is excluded from net income (loss) per common stock because the redemption value approximates fair value. For the Three Months Ended June 30, 2023 2022 Common stock subject to redemption Common stock Common stock subject to redemption Common stock Basic and diluted net loss per share Numerator: Allocation of net loss $ (212,999 ) $ (346,585 ) $ (968,453 ) $ (368,626 ) Denominator Weighted-average shares outstanding 3,508,852 5,709,500 15,000,000 5,709,500 Basic and diluted net loss per share $ (0.06 ) $ (0.06 ) $ (0.06 ) $ (0.06 ) For the Nine Months Ended June 30, 2023 2022 Common stock subject to redemption Common stock Common stock subject to redemption Common stock Basic and diluted net income (loss) per share Numerator: Allocation of net income (loss) $ 12,296 $ 8,004 $ (2,712,943 ) $ (1,032,636 ) Denominator Weighted-average shares outstanding 8,770,367 5,709,500 15,000,000 5,709,500 Basic and diluted net income (loss) per share $ 0.00 $ 0.00 $ (0.18 ) $ (0.18 )
Stock-Based Compensation	Stock-Based Compensation The Company accounts for share-based payments in accordance with FASB ASC Topic 718, “Compensation—Stock Compensation,” (“ASC 718”) which requires that all equity awards be accounted for at their “fair value.” The Company measures and recognizes compensation expense for all share-based payments on their estimated fair values measured as of the grant date. These costs are recognized as an expense in the condensed statements of operations upon vesting, once the applicable performance conditions are met, with an offsetting increase to additional paid-in On June 16, 2021, the Sponsor transferred 50,000 shares to each of its Chief Executive Officer and to its President and 35,000 shares to each of its three 27,963 and $ compensation for the three and nine months ended June 30, 2023, and 2022, respectively. At June 30, 2023, there are 11,250 shares that remain unvested. Total unrecognized compensation expense related to the unvested shares at June 30, 2023 amounted to $27,965 and is expected to be recognized through August 17, 2023 On June 26, 2023, the Sponsor allocated 270,000 90,000 100,000 207,200 190,000 180,000 90,000 90,000
Income Taxes	Income Taxes The Company accounts for income taxes under ASC 740, “Income Taxes.” ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2023 and September 30, 2022. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income taxation by major taxing authorities since inception. These examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. As of June 30, 2023, and September 30, 2022, the Company’s deferred tax asset had a full valuation allowance recorded against it. Our effective tax rate was 96.28 0.00 Our effective tax rate was 17.26% and 0.00% for the three months ended June 30, 2023 and 2022. 21 n and stock-based compensation expenses. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of carrying value, excluding gross unrealized holding loss, and fair value of held to maturity securities	There were no held to maturity securities on June 30, 2023. The carrying value, excluding gross unrealized holding loss, and fair value of held to maturity securities on September 30, 2022 is as follows: Carrying Value as of September 30, 2022 Gross Unrealized Gains Gross Unrealized Losses Fair Value as of September 30, 2022 Cash $ 320 $ — $ — $ 320 U.S. Treasury Bills 150,844,605 19,242 — 150,863,847 $ 150,844,925 $ 19,242 $ — $ 150,864,167
Summary of common stock reflected in the balance sheets are reconciled	At June 30, 2023 and September 30, 2022, the common stock reflected in the balance sheets are reconciled in the following table: Gross Proceeds $ 150,000,000 Proceeds allocated to Public Warrants (11,700,000 ) Issuance costs related to common stock (3,261,589 ) Remeasurement of carrying value to redemption value 14,961,589 Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes) 548,862 Common stock subject to possible redemption – September 30, 2022 150,548,862 Redemptions (117,079,879 ) Remeasurement of carrying value to redemption value 3,477,548 Common stock subject to possible redemption – June 30, 2023 $ 36,946,531
Schedule of basic and diluted net loss per share	Accretion of the carrying value of common stock subject to redemption value is excluded from net income (loss) per common stock because the redemption value approximates fair value. For the Three Months Ended June 30, 2023 2022 Common stock subject to redemption Common stock Common stock subject to redemption Common stock Basic and diluted net loss per share Numerator: Allocation of net loss $ (212,999 ) $ (346,585 ) $ (968,453 ) $ (368,626 ) Denominator Weighted-average shares outstanding 3,508,852 5,709,500 15,000,000 5,709,500 Basic and diluted net loss per share $ (0.06 ) $ (0.06 ) $ (0.06 ) $ (0.06 ) For the Nine Months Ended June 30, 2023 2022 Common stock subject to redemption Common stock Common stock subject to redemption Common stock Basic and diluted net income (loss) per share Numerator: Allocation of net income (loss) $ 12,296 $ 8,004 $ (2,712,943 ) $ (1,032,636 ) Denominator Weighted-average shares outstanding 8,770,367 5,709,500 15,000,000 5,709,500 Basic and diluted net income (loss) per share $ 0.00 $ 0.00 $ (0.18 ) $ (0.18 )

Organization, Business Operat_2

Organization, Business Operations and Going Concern (Details Narrative) - USD ($)

1 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Aug. 08, 2023

Aug. 02, 2023

Jun. 16, 2023

Feb. 23, 2023

Feb. 02, 2023

Jan. 20, 2023

Nov. 10, 2022

Aug. 17, 2021

Jul. 31, 2022

Mar. 31, 2023

Jun. 30, 2023

Sep. 30, 2022

Aug. 16, 2022

May 09, 2022

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Date of incorporation

Nov. 05, 2020

Transaction costs

$ 3,537,515

Underwriting commissions

1,500,000

Other offering costs

2,037,515

Proceeds held in trust account

$ 150,000,000

$ 37,158,121

$ 150,844,925

Trust assets value per unit

$ 10

Maturity period of government securities

185 days

185 days

Redemption outstanding public shares

100%

Percentage of trust assets for acquisition

80%

Percentage of ownership for acquisition

50%

Net tangible assets for acquisition

$ 5,000,001

Extended period from IPO closing to complete acquisition

18 months

Percentage of public shares to be redeemed

100%

Interest amount to pay dissolution expenses

$ 100,000

Minimum trust proceeds per share

$ 10

Operating account

$ 40,000

Proceeds from sale of restricted investments

986,141

182,069

Temporary equity, accretion to redemption value

$ 3,477,548

$ 14,961,589

Threshold date for consummation of business combination

Feb. 17, 2024

Aug. 17, 2023

Feb. 17, 2023

Feb. 17, 2023

Number of days prior to the threhold date of completion of business combination in which the business combination agreement could be terminated

15 days

Net working capital excluding income tax and franchise tax payable

$ 7,600,000

Redemption price

$ 10.53

$ 10.04

Excise tax payable

$ 1,170,799

$ 0

Inflation Reduction Act 2022 [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Percentage Of Excise Tax At Fair Market Value Of The Shares Repurchased

1%

Percentage of Excise Tax

1%

First Amendment To The Business Combination Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Threshold date for termination of business combination agreement

Jan. 31, 2023

Rezolve [Member] | Standby Equity Purchase Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Period for which the issue is open

36 months

Common stock issued but not subscribed not value

$ 250,000,000

Subsequent Event [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Amount deposited into trust account

354,502

Subsequent Event [Member] | Common Stock [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Temporary equity, accretion to redemption value

$ 12,095,215

Temporary equity shares redeemed during the period share

1,145,503

Redemption price

$ 10.56

Subsequent Event [Member] | Extension Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

$ 70,900

Subsequent Event [Member] | Unsecured Promissory Note [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate loaned amount

$ 425,402

Debt instrument, interest rate, stated percentage

0%

Working Capital Needs Funding [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from related party debt

$ 450,000

Sponsor [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate loaned amount

$ 1,500,000

$ 483,034

Payment for services

$ 44,246

$ 44,246

Sponsor [Member] | Promissory Notes [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Repayments of debt

$ 187,034

Related Party [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Note payable to related parties

2,201,754

$ 251,754

Related Party [Member] | Promissory Notes [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Note payable to related parties

483,034

Related Party [Member] | Four Promissory Notes [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Note payable to related parties

$ 2,433,034

Amended and Restated Business Combination Agreement [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate Stock Consideration

$ 1,600,000,000

Non Redemption Agreements [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds from sale of restricted investments

117,079,879

Threshold date for consummation of business combination

Aug. 17, 2023

Percentage of redeemption of public shares

100%

Temporary equity shares redeemed during the period share

11,491,148

Redemption price

$ 10.19

Excise tax payable

1,170,799

Non Redemption Agreements [Member] | Sponsor [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Temporary equity shares redeemed during the period share

713,057

Redemption price

$ 1.55

IPO [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Proceeds received

36,045

Sponsor fees

$ 230,352

IPO [Member] | Units [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Number of shares issued

15,000,000

Price per share

$ 10

Private Placement [Member] | Private Shares [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Number of shares issued

459,500

Price per share

$ 10

Private Placement [Member] | Private [Member] | Purchase Aggregate [Member]

Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]

Aggregate purchase price

$ 4,595,000

Significant Accounting Polici_4

Significant Accounting Policies - Summary of carrying value, excluding gross unrealized holding loss, and fair value of held to maturity securities (Details)	Sep. 30, 2022 USD ($)
Schedule of Held-to-Maturity Securities [Line Items]
Carrying Value	$ 150,844,925
Gross Unrealized Gains	19,242
Gross Unrealized Losses	0
Fair Value	150,864,167
Cash [Member]
Schedule of Held-to-Maturity Securities [Line Items]
Carrying Value	320
Gross Unrealized Gains	0
Gross Unrealized Losses	0
Fair Value	320
U.S. Treasury Bills [Member]
Schedule of Held-to-Maturity Securities [Line Items]
Carrying Value	150,844,605
Gross Unrealized Gains	19,242
Gross Unrealized Losses	0
Fair Value	$ 150,863,847

Significant Accounting Polici_5

Significant Accounting Policies - Summary of common stock reflected in the balance sheets are reconciled (Details) - USD ($)	9 Months Ended	12 Months Ended
	Jun. 30, 2023	Sep. 30, 2022
Accounting Policies [Abstract]
Gross Proceeds		$ 150,000,000
Proceeds allocated to Public Warrants		(11,700,000)
Issuance costs related to common stock		(3,261,589)
Remeasurement of carrying value to redemption value	$ 3,477,548	14,961,589
Subsequent remeasurement of carrying value to redemption value – Trust interest income (excluding the amount that can be withdrawn from Trust Account for taxes)		548,862
Common stock subject to possible redemption	36,946,531	$ 150,548,862
Redemptions	$ (117,079,879)

Schedule of basic and diluted n

Schedule of basic and diluted net loss per share (Details) - USD ($)	3 Months Ended						9 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Dec. 31, 2022	Jun. 30, 2022	Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2023	Jun. 30, 2022
Allocation of net loss	$ (559,584)	$ (27,143)	$ 607,027	$ (1,337,079)	$ (372,386)	$ (2,036,114)	$ 20,300	$ (3,745,579)
Redeemable Common Stock [Member]
Allocation of net loss	$ (212,999)			$ (968,453)			$ 12,296	$ (2,712,943)
Weighted-average shares outstanding	3,508,852			15,000,000			8,770,367	15,000,000
Weighted-average shares outstanding	3,508,852			15,000,000			8,770,367	15,000,000
Basic and diluted net loss per share	$ (0.06)			$ (0.06)			$ 0	$ (0.18)
Basic and diluted net loss per share	$ (0.06)			$ (0.06)			$ 0	$ (0.18)
Common Stock [Member]
Allocation of net loss	$ (346,585)			$ (368,626)			$ 8,004	$ (1,032,636)
Weighted-average shares outstanding	5,709,500			5,709,500			5,709,500	5,709,500
Weighted-average shares outstanding	5,709,500			5,709,500			5,709,500	5,709,500
Basic and diluted net loss per share	$ (0.06)			$ (0.06)			$ 0	$ (0.18)
Basic and diluted net loss per share	$ (0.06)			$ (0.06)			$ 0	$ (0.18)

Significant Accounting Polici_6

Significant Accounting Policies (Details Narrative)					3 Months Ended		9 Months Ended
	Jun. 30, 2023 USD ($) shares	Jun. 26, 2023 USD ($) shares	Aug. 17, 2021 USD ($)	Jun. 16, 2021 USD ($) shares	Jun. 30, 2023 USD ($) shares	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) Director shares	Jun. 30, 2022 USD ($)	Sep. 30, 2022 USD ($) shares
Cash and cash equivalents | $	$ 40,464				$ 40,464		$ 40,464		$ 177,578
Maturity period of government securities			185 days				185 days
Exceed limit | $							$ 250,000
Shares of common stock subject to possible redemption	3,508,852				3,508,852		3,508,852		15,000,000
Fair value of converted shares | $		$ 207,200		$ 509,552
Compensation expense | $	$ 27,963	$ 106,400			$ 27,963	$ 83,889	$ 27,963	$ 83,889
Award Vesting Period date	Aug. 17, 2023
Offering costs | $			$ 3,537,515
Underwriting commissions | $			1,500,000
Other offering costs | $			$ 2,037,515
Effective income tax reconciliation percentage					17.26%	0%	96.28%	0%
Statutory tax rate percentage							21%	21%
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		190,000
Share-Based Payment Arrangement, Tranche Two [Member]
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		90,000
Share-Based Payment Arrangement, Tranche One [Member]
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		90,000
Sponsor [Member]
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested		180,000
US Treasury Securities [Member]
Debt Securities, Held-to-Maturity, Fair Value | $									$ 151,046,320
President [Member]
Shares of common stock transferred				50,000
Director [Member]
Shares of common stock transferred		90,000		35,000
Number of independent directors | Director							3
Three Independent Directors [Member]
Shares of common stock transferred		270,000
Executive Officer [Member]
Shares of common stock transferred		100,000
IPO [Member]
Share-based compensation arrangement by share-based payment award, options, vested, number of shares							100,000
Sharebased compensation arrangement by sharebased payment award options remaining number of shares vested							105,000
Share-based compensation arrangement by share-based payment award, options, nonvested, number of shares	11,250				11,250		11,250
Share-based payment arrangement, nonvested award, cost not yet recognized, amount | $	$ 27,965				$ 27,965		$ 27,965
Warrant [Member]
Warrants exercise to purchase common stock							7,500,000

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)		1 Months Ended	3 Months Ended		6 Months Ended	9 Months Ended		12 Months Ended
	Nov. 10, 2022	Jul. 31, 2022	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Sep. 30, 2022	May 09, 2022
Related Party Transaction [Line Items]
Administrative fees expense			$ 30,000	$ 30,000		$ 90,000	$ 90,000
Working Capital Loans [Member]
Related Party Transaction [Line Items]
Loan amount convertible into common stock						$ 1,500,000
Loan conversion price			$ 10			$ 10
Trust Account Contribution [Member]
Related Party Transaction [Line Items]
Proceeds from related party debt	$ 1,500,000
Working Capital Needs Funding [Member]
Related Party Transaction [Line Items]
Proceeds from related party debt	450,000
Sponsor [Member]
Related Party Transaction [Line Items]
Aggregate loaned amount	$ 1,500,000								$ 483,034
Payment for services		$ 44,246			$ 44,246
Sponsor [Member] | Working Capital Loans [Member]
Related Party Transaction [Line Items]
Line of Credit Facility, Maximum Amount Outstanding During Period						$ 0		$ 0
Sponsor [Member] | Promissory Notes [Member]
Related Party Transaction [Line Items]
Repayments of debt		$ 187,034
Related Party [Member]
Related Party Transaction [Line Items]
Note payable to related parties			$ 2,201,754			2,201,754		$ 251,754
Monthly fee						$ 10,000
Related Party [Member] | Promissory Notes [Member]
Related Party Transaction [Line Items]
Note payable to related parties									$ 483,034

Commitments and Contingencies (

Commitments and Contingencies (Details Narrative) - USD ($)

9 Months Ended

Aug. 02, 2023

Jun. 16, 2023

Feb. 23, 2023

Feb. 02, 2023

Jan. 20, 2023

Oct. 02, 2021

Aug. 18, 2021

Aug. 17, 2021

May 29, 2021

Feb. 08, 2021

Jun. 30, 2023

Sep. 30, 2022

Underwriting discount percentage

1%

Underwriting commissions

$ 1,500,000

Deferred underwriting commission payable

$ 225,000

Deferred underwriting commission expired

$ 225,000

Advisory fee percentage for initial public offering

1%

Advisory fee for IPO amount if underwriters' option is not exercised

$ 1,500,000

Advisory fee paid

$ 1,500,000

Advisory fee for business combination amount if underwriters' option is not exercised

$ 3,000,000

Marketing agreement fee percentage for business combination

2.25%

Marketing agreement fee for business combination amount if underwriters' option is not exercised

$ 3,375,000

Capital market advisory fee for business combination

$ 2,500,000

Cash fee percentage for target business introduction in business combination

1%

Long Term Purchase Commitment Amount Paid

$ 120,000

Long-Term Purchase Commitment, Amount

$ 1,030,000

Threshold Date For Consummation Of Business Combination

Feb. 17, 2024

Aug. 17, 2023

Feb. 17, 2023

Feb. 17, 2023

Redemption price

$ 10.53

$ 10.04

Representative Shares [Member]

Shares Issued, Price Per Share

$ 0.0001

Northland Securities, Inc. [Member] | Representative Shares [Member]

Stock Issued During Period, Shares, Other

87,500

Early Bird Capital, Inc. [Member] | Representative Shares [Member]

Stock Issued During Period, Shares, Other

87,500

Amended and Restated Business Combination Agreement [Member]

Advisory fee for business combination amount if underwriters' option is not exercised

$ 8,750,000

Aggregate Stock Consideration

$ 1,600,000,000

Purchase Agreement [Member] | YA II PN, Ltd. [Member]

Value of ordinary shares expected to issue

$ 250,000,000

Non Redemption Agreements [Member]

Threshold Date For Consummation Of Business Combination

Aug. 17, 2023

Redemption price

$ 10.19

Temporary equity shares redeemed during the period shares

11,491,148

Number of Shares Allocated in Exchange for Non Redeemption of Public Shares

75,000

Non Redemption Agreements [Member] | Sponsor [Member]

Redemption price

$ 1.55

Temporary Equity Shares Redeemed During the Period Value

$ 1,102,909

Temporary equity shares redeemed during the period shares

713,057

Recurring Fair Value Measurem_2

Recurring Fair Value Measurements (Details Narrative)	9 Months Ended
	Jun. 30, 2023
US Treasury Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Term of restricted investments	185 days

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)				9 Months Ended	12 Months Ended
	Aug. 08, 2023	Aug. 02, 2023	Jul. 28, 2023	Jun. 30, 2023	Sep. 30, 2022	Aug. 09, 2023	Aug. 04, 2023	Nov. 10, 2022	May 09, 2022
Subsequent Event [Line Items]
Proceeds from sale of restricted investments				$ 986,141	$ 182,069
Temporary equity, accretion to redemption value				$ 3,477,548	$ 14,961,589
Redemption price				$ 10.53	$ 10.04
Sponsor [Member]
Subsequent Event [Line Items]
Debt instrument, face amount								$ 1,500,000	$ 483,034
Subsequent Event [Member]
Subsequent Event [Line Items]
Minimum net worth required for compliance							$ 5,000,001
Amount deposited into trust account		$ 354,502
Proceeds from sale of restricted investments		70,900
Subsequent Event [Member] | Extension Note [Member]
Subsequent Event [Line Items]
Proceeds from sale of restricted investments	$ 70,900
Subsequent Event [Member] | Promissory Note [Member]
Subsequent Event [Line Items]
Debt instrument, face amount						$ 91,740.5
Subsequent Event [Member] | Unsecured Promissory Note [Member]
Subsequent Event [Line Items]
Debt instrument, face amount		$ 425,402
Debt instrument, interest rate, stated percentage		0%
Subsequent Event [Member] | Common Stock [Member]
Subsequent Event [Line Items]
Temporary equity, accretion to redemption value		$ 12,095,215
Temporary equity shares redeemed during the period shares		1,145,503
Redemption price		$ 10.56
Subsequent Event [Member] | Sponsor [Member] | Promissory Note [Member]
Subsequent Event [Line Items]
Debt instrument, face amount			$ 125,245
Debt instrument, interest rate during period			0%